MiMedx Group Financial Ratios
NASDAQ: MDXGHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MiMedx Group ratio analysis
MiMedx Group earned a net margin of 11.6% in FY 2025, down from 12.2% a year earlier. Gross margin was 82.6% compared with a median of 84.2% over the prior 9 years. Return on equity reached 18.9%, meaning MiMedx Group generated 0.19 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.07 versus 0.10 the year before, and the current ratio was 4.32. At the end of FY 2025, MDXG traded at 20.3 times earnings; across the 4 fiscal years shown, its year-end P/E ranged from 20.3 to 32.8, with a median of 23.1. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
MiMedx Group financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 20.25 | 32.82 | 23.70 | — | — | — | — | — | 22.52 | — |
| Price / sales | 2.29 | 3.87 | 3.18 | 1.17 | 2.75 | 3.96 | 2.56 | 0.60 | 4.17 | 4.23 |
| Price / book | 3.73 | 6.99 | 7.16 | — | 8,128.47 | — | 22.29 | 4.36 | 18.13 | 19.53 |
| Gross margin | 82.6% | 82.8% | 83.0% | 82.0% | 83.6% | 84.2% | 85.6% | 89.9% | 89.0% | 86.0% |
| Operating margin | 15.3% | 16.9% | 11.5% | -5.5% | -2.9% | -18.3% | -7.1% | -1.1% | 14.4% | 0.4% |
| Net margin | 11.6% | 12.2% | 18.1% | -11.3% | -4.2% | -19.9% | -8.5% | -8.3% | 20.2% | 0.2% |
| Free cash flow margin | 17.7% | 19.0% | 7.7% | -7.2% | -2.1% | -12.2% | -13.2% | 10.0% | 19.6% | 10.8% |
| Return on equity (ROE) | 18.9% | 22.0% | 40.8% | — | -12,542.7% | — | -74.4% | -60.4% | 87.7% | 0.8% |
| Return on assets (ROA) | 14.2% | 16.1% | 24.4% | -17.6% | -5.5% | -24.4% | -15.3% | -24.4% | 53.4% | 0.3% |
| Debt / equity | 0.07 | 0.10 | 0.34 | — | 586.91 | — | 1.91 | 0.00 | — | — |
| Current ratio | 4.32 | 4.21 | 3.57 | 3.08 | 3.51 | 2.71 | 1.83 | 1.03 | 1.06 | 0.98 |
| Revenue growth | 20.0% | 8.5% | 20.0% | 10.7% | -2.5% | -17.0% | -16.7% | 11.8% | 44.8% | 18.4% |
| EPS growth | 14.3% | -24.3% | — | — | — | — | — | -150.0% | — | -100.0% |